AAAAAA

   
Results: 1-10 |
Results: 10

Authors: BREGNI M SHAMMAH S MALAFFO F DINICOLA M MILANESI M MAGNI M MATTEUCCI P RAVAGNANI F JORDAN CT SIENA S GIANNI AM
Citation: M. Bregni et al., ADENOVIRUS VECTORS FOR GENE TRANSDUCTION INTO MOBILIZED BLOOD CD34(+)CELLS, Gene therapy, 5(4), 1998, pp. 465-472

Authors: BREGNI M SIENA S DINICOLA M ZAMBETTI M MATTEUCCI P BONADONNA G GIANNI AM
Citation: M. Bregni et al., DOSE-RESPONSE EFFECT OF CYCLOPHOSPHAMIDE IN LOCALLY ADVANCED METASTATIC BREAST-CANCER/, Bone marrow transplantation, 21, 1998, pp. 210-210

Authors: DINICOLA M BREGNI M MILANESI M LONGONI P MATTEUCCI P SIENA S JORDAN CT GIANNI AM
Citation: M. Dinicola et al., IL-2 AND IL-12 INCREASE GENE TRANSDUCTION BY RECOMBINANT ADENOVIRUS INTO PRIMARY HUMAN-LYMPHOCYTES, Bone marrow transplantation, 21, 1998, pp. 385-385

Authors: BREGNI M SIENA S DINICOLA M BONAZZI C MARZOLA M CANTU MG LANDONI F MAGNI M DEVIZZI L MATTEUCCI P MANGIONI C GIANNI AM
Citation: M. Bregni et al., ADVANCED OVARIAN-CANCER IS HIGHLY RESPONSIVE TO A FIRST, BUT NOT TO A2ND CYCLE, OF HIGH-DOSE CARBOPLATIN (HD-CARBO), Bone marrow transplantation, 21, 1998, pp. 803-803

Authors: DINICOLA M SIENA S BREGNI M BELLI N MILANESI M RUFFINI PA MALAFFO F MATTEUCCI P RAVAGNANI F GIANNI AM
Citation: M. Dinicola et al., BENEFITS OF BLOOD-CELL TRANSPLANT CRYOPRESERVATION WITH OXYPOLYGELATINE (GELIFUNDOL) PLASMA SUBSTITUTE (VOL 18, PG 619, 1996), Bone marrow transplantation, 19(4), 1997, pp. 405-405

Authors: CITTERIO G FRAGASSO G ROSSETTI E DILUCCA G BUCCI E FOPPOLI M GUERRIERI R MATTEUCCI P POLASTRI D SCAGLIETTI U TRESOLDI M CHIERCHIA SL RUGARLI C
Citation: G. Citterio et al., ISOLATED LEFT-VENTRICULAR FILLING ABNORMALITIES MAY PREDICT INTERLEUKIN-2-INDUCED CARDIOVASCULAR TOXICITY, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 134-141

Authors: FORTIS C GALLI L CONSOGNO G CITTERIO G MATTEUCCI P SCAGLIETTI U BUCCI E
Citation: C. Fortis et al., SERUM LEVELS OF SOLUBLE CELL-ADHESION MOLECULES (ICAM-1, VCAM-1, E-SELECTIN) AND OF CYTOKINE TNF-ALPHA INCREASE DURING INTERLEUKIN-2 THERAPY, Clinical immunology and immunopathology, 76(2), 1995, pp. 142-147

Authors: BESANA C BORRI A BUCCI E CITTERIO G DILUCCA G FORTIS C MATTEUCCI P TOGNELLA S TRESOLDI M BAIOCCHI C LANDONIO G GHISLANDI E RUGARLI C
Citation: C. Besana et al., TREATMENT OF ADVANCED RENAL-CELL CANCER WITH SEQUENTIAL INTRAVENOUS RECOMBINANT INTERLEUKIN-2 AND SUBCUTANEOUS ALPHA-INTERFERON, European journal of cancer, 30A(9), 1994, pp. 1292-1298

Authors: MATTEUCCI P TRESOLDI M CHIESA G TOGNELLA S CITTERIO G FORTIS C BESANA C RUGARLI C
Citation: P. Matteucci et al., INTRAPLEURAL ADMINISTRATION OF INTERLEUKIN-2 AND LAK CELLS IN LOCALLYADVANCED NON-SMALL-CELL LUNG-CANCER - A CASE-REPORT, Tumori, 80(3), 1994, pp. 246-250

Authors: MATTEUCCI P REGAZZONI CS FORESTI GL
Citation: P. Matteucci et al., REAL-TIME APPROACH TO 3-D OBJECT TRACKING IN COMPLEX SCENES, Electronics Letters, 30(6), 1994, pp. 475-477
Risultati: 1-10 |